AI Company Launches Remote Care Service for Chronic Conditions

Biofourmis, a Boston-based company focused on artificial intelligence-driven virtual care and digital therapeutics, has launched Bioformis Care, a service that aims to deliver high-quality remote care to patients with chronic conditions.

Biofourmis Care will focus on improving provider adherence to care guidelines and detecting patterns of clinical deterioration to enable earlier interventions.

The service includes automated medication management, allowing care teams to adjust medications remotely for improved personalized therapy.

Biofourmis’ Care@Home technology platform now spans across the care continuum with a Hospital@Home platform for acute conditions; remote patient management for post-discharge care; and now, virtual specialty care for longitudinal chronic disease management.

Biofourmis Care will initially focus on care for five conditions: heart failure, hypertension, diabetes, lipid management, and atrial fibrillation. The specialty care programs will be delivered remotely by Biofourmis’ health navigators, who are frontline care coordinators, and a multidisciplinary team of licensed clinicians, including physicians, nurses, and advance practice providers.

According to the press release, specialty care accounts for 70 percent of all healthcare spending in the United States, and up to 40 percent of specialty care visits are deemed preventable. Additionally, one in four patients do not have easy and timely access to specialists. Remote patient monitoring can assist in closing the gaps.

“There has been a lot of focus on primary care as value-based care continues to expand; however, our novel virtual specialty care model will have an outsized impact on reducing total cost of care and improving quality of life and health outcomes,” Maulik Majmudar, MD, chief medical officer and co-founder of Biofourmis and a cardiologist, said in the press release. “That’s because our robust care management platform is augmented by sophisticated software algorithms for medication optimization and supported by a 24/7 clinical care team.”

For the best possible care coordination, the care teams partner with the patient’s current primary and specialty care providers.

Biofourmis’s clinical team will augment the patient’s providers in the following areas:

• Managing their chronic conditions
• Improving care quality through adherence to guideline-directed medical therapies (GDMT)
• Identifying patients with early signs of clinical deterioration through AI-and machine learning-based algorithms
• Driving timely interventions to improve patient outcomes

“Our licensed and highly qualified clinical care teams will be an extension of the health system’s or physician’s care team, virtually engaging patients, coaching them on adherence, and monitoring their vitals to safely prevent hospitalizations and improve quality of life," said Kuldeep Singh Rajput, CEO and founder of Biofourmis, in the press release.

Recently, Biofourmis announced a partnership with UCI Health to improve their AI-powered remote patient monitoring practices.